DifGen Pharmaceuticals and Apotex Celebrate FDA Approval for New Generic Nintedanib Soft Gel Capsules DifGen Pharmaceuticals and Apotex announce FDA approval of new generic Nintedanib capsules, offering affordable treatment options for patients in the U.S.

DifGen Pharmaceuticals and Apotex Celebrate FDA Approval for New Generic Nintedanib Soft Gel Capsules #United_States #Miramar #Apotex #DifGen_Pharmaceuticals #Nintedanib

DifGen Pharmaceuticals Achieves Crucial FDA Approval for Generic Mesalamine Capsules DifGen Pharmaceuticals has secured FDA approval for generic Mesalamine extended-release capsules, enhancing patient access to affordable medications.

DifGen Pharmaceuticals Achieves Crucial FDA Approval for Generic Mesalamine Capsules #United_States #Miramar #DifGen_Pharmaceuticals #PENTASA #M_esalamine